INFO

Info

18F-DOPA use in Parkinsonism

On October 10, 2019, the FDA approved the use of 18F-DOPA in positron emission tomography to visualize dopaminergic nerve terminals in the striatum for the

Read More »
Info

Prostate cancer

Innovative treatment for metastatic prostate cancer with 177-Lu-PSMA. Prostate cancer is the most common cancer in older men (over 50) and the second cause of

Read More »